Concepedia

Christine Fandozzi

CF

25

Publications

1.6K

Citations

18

H-Index

2007

Active since

Affiliations

United States Military Academy(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Bristol-Myers Squibb (United States)

Seagen (United States)

Incyte (United States)

Christine Fandozzi is an author at United States Military Academy specializing in medicine, drug discovery, and pharmacology.

Top concepts

Publications per year

2007–2022

25

Publications

25

MK-5172, a Selective Inhibitor of Hepatitis C Virus NS3/4a Protease with Broad Activity across Genotypes and Resistant Variants

Vincenzo Summa, Steven W. Ludmerer, John A. McCauley et al. · Antimicrobial Agents and Chemotherapy · 2012 · 254 citations · Full text

Discovery of MK-5172, a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor

Steven J. Harper, John A. McCauley, Michael T. Rudd et al. · ACS Medicinal Chemistry Letters · 2012 · 201 citations · Full text

, , +19

Discovery of MK‐8742: An HCV NS5A Inhibitor with Broad Genotype Activity

Craig A. Coburn, Peter T. Meinke, Wei Chang et al. · ChemMedChem · 2013 · 196 citations · Full text

, , +17

Discovery of Vaniprevir (MK-7009), a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor

John A. McCauley, Charles McIntyre, Michael T. Rudd et al. · Journal of Medicinal Chemistry · 2010 · 176 citations

, , +17

MK-7009, a Potent and Selective Inhibitor of Hepatitis C Virus NS3/4A Protease

Nigel J. Liverton, Steven S. Carroll, Jillian DiMuzio et al. · Antimicrobial Agents and Chemotherapy · 2009 · 141 citations · Full text

, , +17

Rows per page

1–5 of 25